Showing results (201-210 of 284) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liverA Chamba, J Neuberger, A Strain, et al.
The Quarterly Journal of Medicine|August 1, 1993
Radioiodine therapy for hyperthyroidism in young patients--perception of risk and useM A Baxter, P M Stewart, J Daykin, et al.
Clinical Endocrinology|June 26, 1998
Retinoid X receptor expression in the normal pituitary and clinically 'non-functioning' pituitary tumoursN J Gittoes, C J McCabe, J Verhaeg, et al.
Clinical Endocrinology|May 14, 1998
Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegalyP H Davies, S E Stewart, L Lancranjan, et al.
Clinical Endocrinology|September 1, 1988
Dexamethasone-suppressible hyperaldosteronism: studies on overproduction of 18-hydroxycortisol in three affected family membersJ R Davis, D Burt, J E Corrie, et al.
The American Journal of Physiology|June 1, 1993
11 beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in the rat colonC B Whorwood, P C Barber, J Gregory, et al.
Clinical Endocrinology|December 23, 1998
Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disordersP M Clark, I Neylon, P R Raggatt, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegalyP M Stewart, K F Kane, S E Stewart, et al.
Clinical Endocrinology|November 1, 1995
The Birmingham pituitary database: auditing the outcome of the treatment of acromegalyD Jenkins, I O'Brien, A Johnson, et al.
Acta Endocrinologica|May 1, 1984
The hypothalamic-pituitary-thyroid axis in type 1 diabetes: influence of diabetic metabolic controlI A MacFarlane, M C Sheppard, E G Black, et al.
Pageof 29